Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia

被引：0
|
作者：
Karlo Perica
Jessica Flynn
Kevin J. Curran
Isabelle Rivere
Xiuyan Wang
Brigitte Senechal
Elizabeth Halton
Claudia Diamonte
John Pineda
Yvette Bernal
Mithat Gonen
Michel Sadelain
Renier J. Brentjens
Jae H. Park
机构：
[1] Cellular Therapy Center,Department of Medicine
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology & Biostatistics
来源：
Leukemia | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3268 / 3271
页数：3
相关论文
共 50 条
  • [1] Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia
    Perica, Karlo
    Flynn, Jessica
    Curran, Kevin J.
    Rivere, Isabelle
    Wang, Xiuyan
    Senechal, Brigitte
    Halton, Elizabeth
    Diamonte, Claudia
    Pineda, John
    Bernal, Yvette
    Gonen, Mithat
    Sadelain, Michel
    Brentjens, Renier J.
    Park, Jae H.
    LEUKEMIA, 2021, 35 (11) : 3268 - 3271
  • [2] Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL.
    Perica, Karlo
    Flynn, Jessica
    Curran, Kevin Joseph
    Wang, Xiuyan
    Halton, Elizabeth
    Diamonte, Claudia
    Pineda, John
    Bernal, Yvette
    Gonen, Mithat
    Riviere, Isabelle
    Sadelain, Michel
    Brentjens, Renier J.
    Park, Jae Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Yang, Tingting
    Dong, Yetian
    Zhang, Mingming
    Feng, Jingjing
    Fu, Shan
    Xiao, Pingnan
    Hong, Ruimin
    Xu, Huijun
    Cui, Jiazhen
    Huang, Simao
    Wei, Guoqing
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    BLOOD, 2024, 144 : 2819 - 2819
  • [4] Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
    Shahid, Sanam
    Ramaswamy, Kavitha
    Flynn, Jessica
    Mauguen, Audrey
    Perica, Karlo
    Park, Jae H.
    Forlenza, Christopher J.
    Shukla, Neerav N.
    Steinherz, Peter G.
    Margossian, Steven P.
    Boelens, Jaap Jan
    Kernan, Nancy A.
    Curran, Kevin J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (02): : 72.e1 - 72.e8
  • [5] Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
    Phely, Laurent
    Hensen, Luca
    Faul, Christoph
    Ruff, Christer Alexander
    Schneider, Dina
    Bethge, Wolfgang Andreas
    Lengerke, Claudia
    JAMA ONCOLOGY, 2024, 10 (06) : 821 - 824
  • [6] Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
    Park, Jae H.
    Riviere, Isabelle
    Gonen, Mithat
    Wang, Xiuyan
    Senechal, Brigitte
    Curran, Kevin J.
    Sauter, Craig
    Wang, Yongzeng
    Santomasso, Bianca
    Mead, Elena
    Roshal, Mikhail
    Maslak, Peter
    Davila, Marco
    Brentjens, Renier J.
    Sadelain, Michel
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (05): : 449 - 459
  • [7] An owner's manual for CD19 "CAR"-T cell therapy in managing pediatric and young adult B-cell acute lymphoblastic leukemia
    Laetsch, Theodore W.
    Yanik, Gregory A.
    Boyer, Michael W.
    Rheingold, Susan R.
    BLOOD REVIEWS, 2021, 50
  • [8] Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia
    Myers, Regina M.
    Devine, Kaitlin
    Li, Yimei
    Lawrence, Sophie
    Leahy, Allison Barz
    Liu, Hongyan
    Vernau, Lauren
    Callahan, Colleen
    Baniewicz, Diane
    Kadauke, Stephan
    McGuire, Regina
    Wertheim, Gerald B.
    Kulikovskaya, Irina
    Gonzalez, Vanessa E.
    Fraietta, Joseph A.
    DiNofia, Amanda M.
    Hunger, Stephen P.
    Rheingold, Susan R.
    Aplenc, Richard
    June, Carl H.
    Grupp, Stephan A.
    Wray, Lisa
    Maude, Shannon L.
    BLOOD ADVANCES, 2024, 8 (09) : 2182 - 2192
  • [9] Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia
    Ramona Wullenkord
    Christian Reicherts
    Jan-Henrik Mikesch
    Julia Marx
    Klaus Wethmar
    Jörn Albring
    Simon Call
    Georg Lenz
    Matthias Stelljes
    Annals of Hematology, 2021, 100 : 587 - 589
  • [10] Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia
    Wullenkord, Ramona
    Reicherts, Christian
    Mikesch, Jan-Henrik
    Marx, Julia
    Wethmar, Klaus
    Albring, Joern
    Call, Simon
    Lenz, Georg
    Stelljes, Matthias
    ANNALS OF HEMATOLOGY, 2021, 100 (02) : 587 - 589
12345